Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:KDNY

Chinook Therapeutics (KDNY) Stock Price, News & Analysis

Chinook Therapeutics logo

About Chinook Therapeutics Stock (NASDAQ:KDNY)

Key Stats

Today's Range
$40.39
$40.39
50-Day Range
$38.66
$40.39
52-Week Range
$18.34
$40.51
Volume
N/A
Average Volume
1.19 million shs
Market Capitalization
$2.90 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive KDNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chinook Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KDNY Stock News Headlines

Three Finalists Announced for the 2024 Bloom Burton Award
What's the Best Way to Lower RMD Taxes?
Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain retirement accounts. Without the right strategy, these withdrawals can significantly increase your tax bill and shrink your nest egg. SmartAsset outlines six strategies that could help reduce your RMDs and potentially lower your tax burden. Their free tool can match you with vetted fiduciary financial advisors in your area—professionals legally bound to act in your best interest.tc pixel
Chinook Elementary
Chinook Therapeutics, Inc. (KDNY)
Expert Ratings for Chinook Therapeutics
See More Headlines

KDNY Stock Analysis - Frequently Asked Questions

Chinook Therapeutics, Inc. (NASDAQ:KDNY) released its quarterly earnings data on Tuesday, May, 9th. The company reported ($0.85) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.82) by $0.03. The company's quarterly revenue was down 32.2% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Chinook Therapeutics investors own include Advanced Micro Devices (AMD), Meta Platforms (META), NIO (NIO), Ovintiv (OVV), Plug Power (PLUG), AMC Entertainment (AMC) and Applied Materials (AMAT).

Company Calendar

Last Earnings
5/09/2023
Today
9/20/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:KDNY
CIK
1435049
Fax
N/A
Employees
214
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.52)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$187.87 million
Net Margins
-4,199.93%
Pretax Margin
-4,115.56%
Return on Equity
-58.28%
Return on Assets
-44.72%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.82
Quick Ratio
5.82

Sales & Book Value

Annual Sales
$6.13 million
Price / Sales
473.15
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.91 per share
Price / Book
5.85

Miscellaneous

Outstanding Shares
71,810,000
Free Float
59,749,000
Market Cap
$2.90 billion
Optionable
Optionable
Beta
0.34

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:KDNY) was last updated on 9/20/2025 by MarketBeat.com Staff
From Our Partners